Company Profile

LigandomicsRx LLC is structured around development and achievement of an ability to offer a screening service whereby systematically to enable identification of disease-selective cellular ligands as high-quality drug targets. The effort is to enable selectionof the most promising drug targets: identification of highly disease-selective ligands as drug targets; acceleration of ligand-based drug discovery; minimizing drug adverse side effects; reduce drug attrition rates; and lower pharmaceutical R&D costs